HeyJaredAmy Norton
- Indexed articles, last 90 days
- 29
- Latest publication
- Sep 11, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC (opens the original)
Read excerpt
Adding atezolizumab to stereotactic body radiation therapy (SBRT) did not improve survival outcomes in patients with early-stage, medically inoperable non-small cell lung cancer (NSCLC), according to a phase 3 trial that closed early for futility. The combination resulted in more severe adverse events, including two deaths. "In contrast to the operable setting, atezolizumab did not improve PFS or overall survival in patients with early-stage, inoperable NSCLC treated with SBRT," the study author
Can Response-Adapted Surgery Improve Outcomes in HNSCC? (opens the original)
Read excerpt
In a phase 2 trial of patients with locally advanced head and neck squamous cell carcinoma (HNSCC), neoadjuvant immunochemotherapy (ICT) followed by response-adapted surgery showed promise: Patients who responded to ICT and underwent reduced-volume surgery had a 2-year disease-free survival of 90% and universal laryngeal preservation. “The REMATCH trial provides the first prospective evidence that a response-adapted surgical strategy after [neoadjuvant] ICT is feasible,” the study authors wrote.
Talc Powder Not Linked to Lung Cancer in Women (opens the original)
Read excerpt
A US cohort study of nearly 50,000 women found no consistent association between talc-based body powder use and incident lung cancer. However, certain subgroup analyses suggested a positive association with underarm use. “This analysis does not support an association between talc use and lung cancer, although some subgroup findings may warrant further investigation,” the study authors wrote. However, they added, “considering imprecise effect estimates and inconsistent dose-response patterns, we
Saturated Fat Tied to Worse Survival After Prostate Cancer (opens the original)
Read excerpt
Among patients with nonmetastatic prostate cancer, those in the highest quintile of saturated fat intake after diagnosis had a 24% greater risk for all-cause mortality over the next 13 years. Replacing a small amount of saturated fat with monounsaturated fat would reduce mortality by a similar degree, researchers estimated. “This study suggests that replacing intake of animal fats with plant-based fats or saturated with monounsaturated sources of fats may improve survival among patients with non
Can Accelerated Salvage RT Improve Prostate Cancer Control? (opens the original)
Read excerpt
In a phase 3 trial, hypofractionated salvage radiotherapy (RT) was no more effective than standard RT for patients with biochemical recurrence after radical prostatectomy. Over 4 years, biochemical progression-free survival rates were comparable, while the hypofractionated regimen came with a higher risk for late gastrointestinal (GI) toxicity. Although hypofractionated RT was not superior in this trial, the study authors wrote, “given the comparable oncologic outcomes, toxicity profiles, and qu
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.